Introducing AI into the pharma supply chain is a journey
The proliferation of Artificial Intelligence (AI) in our lives has set about a true revolution in how we collect, organize…
The proliferation of Artificial Intelligence (AI) in our lives has set about a true revolution in how we collect, organize…
Recruiting enough participants and keeping them engaged through lengthy clinical trials is increasingly challenging. In fact, more than 80% of…
A recent survey for GlobalData’s “State of the Biopharmaceutical Industry 2025” report, conducted at the end of 2024, found drug…
In the race to decarbonize the global economy, advanced materials are no longer a luxury - they're a necessity. The…
The global cell and gene therapy (CGT) market is expanding at a rapid rate, and will be worth $76bn by…
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
The obesity therapeutics market has gone from a standing start to the story of the year in biopharmaceuticals - and…
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently…
The latest EU clinical trial regulations must be carefully understood. The Clinical Trial Regulation (CTR) was introduced in the EU…
The inaugural London Biotechnology Show was a major hit with over 3,000 attendees present at the event, including representatives from…